Medication Guide App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Applications

BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Duchenne Muscular Dystrophy

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced completion of the rolling submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for drisapersen, an investigational exon-skipping drug candidate for the treatment of the largest genetically defined subset of Duchenne muscular dystrophy (DMD). DMD...

Posted today in Medical

New Drug Class Slashes 'Bad' Cholesterol, Review Finds

A new class of cholesterol drug could sharply cut "bad" LDL cholesterol in people who don't fare well on commonly used cholesterol-lowering medications called statins, a new research review confirms. The drugs, known as PCSK9 inhibitors, are not on the market yet. But the U.S. Food and Drug Administration (FDA) is expected to decide later this year...

Posted today in Medical

Divorce May Increase Psychosomatic Symptoms in Teens: Study

Teens may have an increased risk for psychosomatic symptoms -- physical problems caused by mental distress -- if their parents separate or divorce, a new study suggests. Those who lived mostly with one parent due to a family breakup had the most psychosomatic symptoms, while those who lived in the same home with both parents had the fewest. Children...

Posted 3 days ago in New Drug Approvals

FDA Approves Cyramza (Ramucirumab) for Use with FOLFIRI in Second-Line Treatment of Metastatic Colorectal Cancer

Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Cyramza (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal...

Posted 3 days ago in Clinical Trials

Malaria Vaccine Candidate has Demonstrated Efficacy Over 3-4 Years of Follow-Up

Final results from a large-scale Phase III trial of the RTS,S malaria vaccine candidate, including the impact of a booster dose, published today in The Lancet, show that the vaccine candidate helped protect children and infants from clinical malaria for at least three years after first vaccination. The latest results demonstrated that vaccination...

Posted today in Medical

Smartphone App Blocks Teens From Texting, Phoning While Driving

A smartphone app that cuts off teenagers' cell service when they turn on the car ignition may help reduce their accident risk, a preliminary new study suggests. Teens appreciate full well that texting is risky, said study lead author Dr. Beth Ebel, an associate professor of pediatrics at the University of Washington School of Medicine. "And they, like...

Posted today in Clinical Trials

aTyr Pharma Receives U.S. FDA Orphan Designation for Resolaris

SAN DIEGO—April 27, 2015 – aTyr Pharma (“aTyr”), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today that Resolaris has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of facioscapulohumeral muscular...

Posted today in Medical

Health Tip: Gear up for Sports

-- Playing on a team is a great way for kids to learn sportsmanship and to get exercise. But it's also important to take precautions aimed at reducing the risk of injury. The Safekids.org website advises parents to: Make sure children get a physical exam before playing. Pack a water bottle during practice and games, encouraging kids to drink frequently. Promote...

Posted today in Medical

Health Tip: Promptly Treat a Minor Burn

-- Burns less than 3 inches in diameter usually can be cared for at home. The U.A. National Safety Council suggests: Hold the burned area under cool running water (or apply a cold compress) until the area is no longer painful when the water or compress is removed. Do not use ice on a burn. Use a sterile, nonstick bandage to loosely cover the burn....

Posted today in Medical

Few Sickle Cell Patients Receiving Beneficial Drug, Study Finds

Few U.S. adults with sickle cell anemia are getting a recommended medication that can help them manage pain, breathing problems and other debilitating symptoms, according to a new study. Using a national database, researchers found that less than one-quarter of sickle cell patients who should have been taking a drug called hydroxyurea actually were. "This...

Read more news...

Recently added consumer and prescribing information: Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix, Natpara

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web3)